[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Eggenhofer E, Popp FC, Mendicino M, Silber P, Hof WVan't, Renner P, Hoogduijn MJ, Pinxteren J, van Rooijen N, Geissler EK, et al. Heart Grafts Tolerized Through Third-Party Multipotent Adult Progenitor Cells Can Be Retransplanted to Secondary Hosts With No Immunosuppression. Stem Cells Transl Med. 2013.
Eggenschwiler R, Loya K, Wu G, Sharma ADeep, Sgodda M, Zychlinski D, Herr C, Steinemann D, Teckman J, Bals R, et al. Sustained Knockdown of a Disease-Causing Gene in Patient-Specific Induced Pluripotent Stem Cells Using Lentiviral Vector-Based Gene Therapy. Stem Cells Transl Med. 2013.
Eggers H, Seidel C, Schrader AJan, Lehmann R, Wegener G, Kuczyk MA, Steffens S. Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder. Med Oncol. 2013;30(4):705.
Eggers H, Krüger M, Stange K, Jonigk D, Biancosino C, Rodt T, Fühner T, Murray T, Grünwald V, Ivanyi P. Sarcoid-Like Lesions Mimicking Pulmonary Metastasis: A Case Series and Review of the Literature. Oncol Res Treat. 2019:1-5.
Eggington HR, Mulholland EJ, Leedham SJ. Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis. Dev Dyn. 2021.
Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B, Dolati S, Hojjat-Farsangi M, et al. The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.
Eghbali A, Anvarinia Y, Sanjari MSoltan, Pakdel F, Seyedsadr M, Mazinani FHosseini, Zare L, Zarei-Kheirabadi M, Satarian L. Erythropoietin Protects against Retinal Damage in A Rat Model of Optic Neuropathy via Glial Suppression. Cell J. 2023;25(5):327-337.
Eghbalsaied S, Kues WA. CRISPR/Cas9-mediated targeted knock-in of large constructs using nocodazole and RNase HII. Sci Rep. 2023;13(1):2690.
Eghbalsaied S, Hyder I, Kues WA. A versatile bulk electrotransfection protocol for murine embryonic fibroblasts and iPS cells. Sci Rep. 2020;10(1):13332.
Egiazarian MA, Strømstad S, Sakshaug T, Nunez-Nescolarde AB, Bethge N, Bjørås M, Scheffler K. Age- and sex-dependent effects of DNA glycosylase Neil3 on amyloid pathology, adult neurogenesis, and memory in a mouse model of Alzheimer's disease. Free Radic Biol Med. 2022.
Egle A, Steurer M, Melchardt T, Weiss L, Gassner FJosef, Zaborsky N, Geisberger R, Catakovic K, Hartmann TNicole, Pleyer L, et al. Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study. Ann Hematol. 2018.
Eglen RM, Randle DH. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?. Assay Drug Dev Technol. 2015.
Eglen RM, Reisine T. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization. SLAS Technol. 2018:2472630318803277.
Eguchi R, Hamano M, Iwata M, Nakamura T, Oki S, Yamanishi Y. TRANSDIRE: data-driven direct reprogramming by a pioneer factor-guided trans-omics approach. Bioinformatics. 2022;38(10):2839-2846.
Eguchi A, Gonzalez AFernanda G, Torres-Bigio SI, Koleckar K, Birnbaum F, Zhang JZ, Wang VY, Wu JC, Artandi SE, Blau HM. TRF2 rescues telomere attrition and prolongs cell survival in Duchenne muscular dystrophy cardiomyocytes derived from human iPSCs. Proc Natl Acad Sci U S A. 2023;120(6):e2209967120.
Eguchi T, Kuboki T. Cellular Reprogramming Using Defined Factors and MicroRNAs. Stem Cells Int. 2016;2016:7530942.
Eguchi T, Sheta M, Fujii M, Calderwood SK. Cancer Extracellular Vesicles, Tumoroid Models, and Tumor Microenvironment. Semin Cancer Biol. 2022.
Eguchi A, Iwasa M, Nakagawa H. Extracellular vesicles in fatty liver disease and steatohepatitis: role as biomarkers and therapeutic targets. Liver Int. 2022.
Eguiarte-Solomon F, Blazanin N, Rho O, Carbajal S, Felsher DW, Tran PT, DiGiovanni J. Twist1 is required for the development of UVB-induced squamous cell carcinoma. Mol Carcinog. 2021.
Egusa S, Ebrahem Q, Mahfouz RZ, Saunthararajah Y. Ligand exchange on gold nanoparticles for drug delivery and enhanced therapeutic index evaluated in acute myeloid leukemia models. Exp Biol Med (Maywood). 2014.
Ehinger E, Kopecky J, Darabi A, Visse E, Edvardsson C, Tomasevic G, Cederberg D, Belting M, Bengzon J, Siesjö P. Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma. BMC Neurol. 2023;23(1):76.
Ehioghae M, Vippa TK, Askins D, Slusarczyk S, Bobo E, Montoya A, Anderson D, Robinson CL, Kaye AD, Urits I. Exploring Orthopedic Stem-Cell Approaches for Osteoarthritis Management: Current Trends and Future Horizons. Curr Pain Headache Rep. 2023.
Ehler ED, Turcotte LM, Skamene S, K Baker S, Das SK, Constine LS, Yuan J, Dusenbery KE. Idiopathic Pneumonitis Syndrome After Total Body Irradiation in Pediatric Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2023.
Ehlert K, Schulte JH, Kühl J-S, Lang P, Eggert A, Voigt S. Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections. J Pediatric Infect Dis Soc. 2021.
Ehlert K, Rossig C, Groll AH, Beyna T, Froehlich B, Juergens H. Diffuse Hemorrhagic Colitis in a Patient With Dyskeratosis Congenita After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation. J Pediatr Hematol Oncol. 2014.